Pharmacogenomics of cancer chemopreventive isothiocyanate compound sulforaphane in the intestinal polyps of ApcMin/+ mice

被引:44
作者
Khor, Tin Oo
Hu, Rong
Shen, Guoxiang
Jeong, Woo-Sik
Hebbar, Vidya
Chen, Chi
Xu, Changjiang
Nair, Sujit
Reddy, Bandaru
Chada, Kiran
Kong, Ah-Ng Tony [1 ]
机构
[1] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmaceut, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Piscataway, NJ 08854 USA
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA
关键词
pharmacogenomics; sulforaphane; ApcMin/; gene regulation; microarray; chemoprevention;
D O I
10.1002/bdd.522
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Sulforaphane (SIN) is an isothiocyanate that is present in widely consumed vegetables. Previous studies have shown that SFN is effective in preventing carcinogenesis induced by carcinogens in rodents. Recently it was found that SFN could also suppress the growth of intestinal polyps in the ApcMin/+ mouse. In the present study, the acute effect of SFN on the gene expression profile in small intestinal polyps of ApcMin/+ mice using Affymetrix microarray was performed. SFN is a strong inducer for phase II drug metabolizing enzymes, which is believed to contribute to its chemopreventive properties. However, the results show that genes involved in apoptosis, cell growth and maintenance rather than the predicted phase II genes were modulated. The proapoptotic genes including MBD4, TNFR-7 and TNF (ligand)-11 were up-regulated while pro-survival genes including cyclin-D2, integrin-beta 1 and Wnt-9A were down-regulated. Interestingly, two genes potentially involved in colorectal carcinogenesis, 15-LOX and COX-2 were found to be increased and decreased, respectively. In conclusion, the results show, for the first time, that chemopreventive agents such as SFN regulate different set of genes involving apoptosis, cell growth/maintenance and inflammation in the small intestinal polyps of ApcMin/+ mice, which could contribute to the overall chemopreventive pharmacological effects. Copyright (c) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:407 / 420
页数:14
相关论文
共 48 条
[1]   Cyclooxygenase and lipoxygenase inhibitors in cancer therapy [J].
Ara, G ;
Teicher, BA .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1996, 54 (01) :3-16
[2]   INVIVO ACTIVATION OF AN DELTA-6 OXYGENASE IN HUMAN SKIN [J].
BAER, AN ;
COSTELLO, PB ;
GREEN, FA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 180 (01) :98-104
[3]   Discovery of a second 15S-lipoxygenase in humans [J].
Brash, AR ;
Boeglin, WE ;
Chang, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) :6148-6152
[4]   Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate [J].
Chung, FL ;
Conaway, CC ;
Rao, CV ;
Reddy, BS .
CARCINOGENESIS, 2000, 21 (12) :2287-2291
[5]   Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice [J].
Conaway, CC ;
Wang, CX ;
Pittman, B ;
Yang, YM ;
Schwartz, JE ;
Tian, DF ;
McIntee, EJ ;
Hecht, SS ;
Chung, FL .
CANCER RESEARCH, 2005, 65 (18) :8548-8557
[6]  
DARET D, 1989, PROSTAGLANDINS, V382, P203
[7]  
DONG M, 2003, CARCINOGENESIS, V342, P307
[8]  
Dove WF, 1995, CANCER SURV, V25, P335
[9]   Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors [J].
DuBois, RN ;
Radhika, A ;
Reddy, BS ;
Entingh, AJ .
GASTROENTEROLOGY, 1996, 110 (04) :1259-1262
[10]   METABOLISM OF OXIDIZED LINOLEIC-ACID - CHARACTERIZATION OF 13-HYDROXYOCTADECADIENOIC ACID DEHYDROGENASE-ACTIVITY FROM RAT COLONIC TISSUE [J].
EARLES, SM ;
BRONSTEIN, JC ;
WINNER, DL ;
BULL, AW .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1081 (02) :174-180